Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
Savino Sciascia(Ospedale San Giovanni Bosco), Dario Roccatello(5T Torino (Italy)), R. Carignola(Ospedale San Luigi Gonzaga), Silvia Gallo Cassarino(A. O. Ordine Mauriziano di Torino), Massimo Radin(Ospedale San Giovanni Bosco), Beatrice Bacco(A. O. Ordine Mauriziano di Torino), Claudio Norbiato(A. O. Ordine Mauriziano di Torino), Barbara Montaruli(A. O. Ordine Mauriziano di Torino), Maria Tiziana Bertero(University of Turin), Mario Bazzan(Ospedale San Giovanni Bosco), Domenico Cosseddu(A. O. Ordine Mauriziano di Torino)
Cited by 29
Related Papers
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
|New England Journal of Medicine|2001|599
GAPSS: the Global Anti-Phospholipid Syndrome Score
|Lara D. Veeken|2013|310
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
|Journal of Clinical Oncology|2005|305
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
|Internal and Emergency Medicine|2008|126